These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2903012)

  • 1. Almitrine decreases compliance of pulmonary arteries in COPD.
    Hervé P; Simonneau G; Duroux P
    Chest; 1988 Nov; 94(5):1119-20. PubMed ID: 2903012
    [No Abstract]   [Full Text] [Related]  

  • 2. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 3. Undetermined utility of almitrine.
    Patz D
    Chest; 1987 May; 91(5):794. PubMed ID: 2882957
    [No Abstract]   [Full Text] [Related]  

  • 4. Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
    Eur J Respir Dis Suppl; 1986; 146():609-718. PubMed ID: 2877898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic bronchopneumopathies. A new therapeutic approach].
    Chrétien J
    Presse Med; 1984 Oct; 13(34):2043-4. PubMed ID: 6149529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH; Kempf P; Mössinger B; Klein G; Costabel U; Würtemberger G; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
    Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
    Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
    Michel O; Sergysels R; Ham H
    Chest; 1988 May; 93(5):1108-10. PubMed ID: 2896103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.
    Chung KF; Barnes PJ
    Br Med J (Clin Res Ed); 1988 Jan; 296(6615):111-5. PubMed ID: 2892564
    [No Abstract]   [Full Text] [Related]  

  • 13. Almitrine decreases the distensibility of the large pulmonary arteries in man.
    Herve P; Musset D; Simonneau G; Wagner W; Duroux P
    Chest; 1989 Sep; 96(3):572-7. PubMed ID: 2569960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical bases for the respiratory action of almitrine].
    Lecomte J; Lagneaux D
    Rev Med Liege; 1986 May; 41(10):451-5. PubMed ID: 2874604
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction.
    Simonneau G; Meignan M; Denjean A; Raffestin B; Harf A; Prost JF
    Chest; 1986 Feb; 89(2):174-9. PubMed ID: 2867861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 18. One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysis.
    Stavchansky S; Doluisio JT; Macleod CM; Szalkowski MB; Bachand RT; Heilman R; Sebree TB; Geary RS
    Biopharm Drug Dispos; 1989; 10(3):247-55. PubMed ID: 2566339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator].
    Rühle KH; Köhler D; Huber G; Matthys H
    Prax Klin Pneumol; 1985 Jun; 39(6):197-203. PubMed ID: 2862627
    [No Abstract]   [Full Text] [Related]  

  • 20. [The first Italian clinical experience with almitrine bismesylate].
    Grassi V; Bottino G; Blasi A; Grassi C
    Rev Mal Respir; 1985; 2 Suppl 1():S53-60. PubMed ID: 2870548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.